| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 85371-64-8 | Pinacidil monohydrate |
≥98% | | 询价 |
| 2 | 85392-79-6 | Indanidine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 854171-35-0 | Indirubin Derivative E804 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 85443-48-7 | Bencianol |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 854601-70-0 | Naloxegol |
≥98% | | 询价 |
| 6 | 74191-85-8 | Doxazosin(UK 33274) |
≥98% | | 询价 |
| 7 | 81-61-8 | Quinalizarin |
≥98% | | 询价 |
| 8 | 1219624-62-0 | A-1048400 |
≥98% | | 询价 |
| 9 | 195704-72-4 | A 127722 |
≥98% | | 询价 |
| 10 | 156467-85-5 | alpha-Conotoxin imi |
≥98% | | 询价 |
| 11 | 1240308-45-5 | A-971432 |
≥98% | | 询价 |
| 12 | 96590-75-9 | Promethazine hibenzate |
≥98% | | 询价 |
| 13 | 66753-47-7 | A 9145C |
≥98% | | 询价 |
| 14 | 135561-94-3 | A 80b |
≥98% | | 询价 |
| 15 | 141887-34-5 | A 81988 |
≥98% | | 询价 |
| 16 | 142383-42-4 | A 83016A |
≥98% | | 询价 |
| 17 | 141872-46-0 | A 81282 |
≥98% | | 询价 |
| 18 | 144141-97-9 | A 80987 |
≥98% | | 询价 |
| 19 | 127875-60-9 | A 80915A |
≥98% | | 询价 |
| 20 | 82-92-8 | Cyclizine |
≥98% | | 询价 |
| 21 | 107767-58-8 | A 802715 |
≥98% | | 询价 |
| 22 | 74313-95-4 | L-DPPG |
≥98% | | 询价 |
| 23 | 141579-87-5 | A 79175 |
≥98% | | 询价 |
| 24 | 134805-77-9 | A 76889 |
≥98% | | 询价 |
| 25 | 136989-30-5 | A 76154 |
≥98% | | 询价 |
| 26 | 167396-23-8 | Aranose |
≥98% | | 询价 |
| 27 | 85-32-5 | 5'-Guanylic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 84845-75-0 | Niperotidine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 29 | 848463-13-8 | SSR128129E free acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 848647-56-3 | J-2156 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 849234-64-6 | BRD-6929 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 849550-67-0 | Cevipabulin fumarate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 849643-15-8 | SU14813 maleate |
≥98% | | 询价 |
| 34 | 849758-42-5 | Platycoside G1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 85031-59-0 | Dihydroartemisinic Acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 850608-87-6 | Riluzole HCl(RP-54274,PK 26124) |
≥98% | | 询价 |
| 37 | 85081-18-1 | NBI-98782 |
≥98% | | 询价 |
| 38 | 851204-35-8 | EP1-antanoist-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 85138-49-4 | BCECF |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | 851599-82-1 | ELN 318463 racemate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 85175-67-3 | Zatebradine(UL-FS-49 UL-FS-49CL) |
≥98% | | 询价 |
| 42 | 85186-71-6 | Driselase |
≥98% | | 询价 |
| 43 | 85187-10-6 | Sphingomyelin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 85187-37-7 | Cloperastine fendizoate |
≥98% | | 询价 |
| 45 | 851881-59-9 | (R)-ADX-47273 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 852055-88-0 | L-Threonine derivative-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 852155-81-8 | HAEGT |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 852329-66-9 | Dutogliptin |
≥98% | | 询价 |
| 49 | 852391-20-9 | Necrostatin 2 S enantiomer |
≥98% | | 询价 |
| 50 | 852947-39-8 | MB-07344 |
≥98% | | 询价 |
| 51 | 853-23-6 | Dehydroisoandrosterone 3-acetate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | 847991-34-8 | MARK Substrate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | 848193-69-1 | Selisistat R-enantiomer |
≥98% | | 询价 |
| 54 | 848217-00-5 | H4 Receptor antagonist 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 848258-31-1 | Pemafibrate racemate |
≥98% | | 询价 |
| 56 | 848301-94-0 | G3-C12 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 135215-95-1 | A 75998 |
≥98% | | 询价 |
| 58 | 34911-55-2 | Bupropion |
≥98% | | 询价 |
| 59 | 1393-48-2 | Thiostrepton |
≥98% | | 询价 |
| 60 | 136451-98-4 | A 73209 |
≥98% | | 询价 |
m.cnreagent.com